Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients
Authors:
Open Access
- 25 November 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 51 (3) , 557-561
Abstract
Objective. To analyse therapeutic management of eosinophilic fasciitis (EF). Methods. We reviewed 34 adult patients with biopsy-proven EF. Analyses focused on the therapeutic management, including treatment modalities, responses and associated or predictive factors. Results. Thirty-four patients were included with a diagnosis age of 53 (15) years. They were featured by cutaneous manifestations (88%) including morphoea (41%), myalgia (86%) and hypereosinophilia (85%). Thirty-two patients (94%) were eligible for treatment evaluation and all received CSs as a first-line therapy. Fifteen patients (47%) received methylprednisolone pulses (MPPs) at treatment initiation and 14 patients (44%) received an immunosuppressive drug (ISD), usually MTX (86%), as a second-line therapy. Complete remission was achieved for 69% of patients, remission with disability 19% and failure 12%. A poor outcome was associated with a diagnosis time delay of >6 months [odds ratio (OR) = 14.7] and the lack of MPPs (OR = 12.9). Conclusion. Our study reports new insights into the therapeutic management of EF: (i) CS treatment remains the standard therapy for EF, taken alone or in association with an ISD; (ii) MPPs at initiation of treatment are associated with a better outcome and a lower need of ISD use; (iii) an ISD, usually MTX, might be useful as a second-line therapy, mainly in patients with morphoea-like lesions. Naturally, these practical conclusions should be confirmed by a prospective and multicentre study.Keywords
This publication has 12 references indexed in Scilit:
- Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three casesRheumatology, 2010
- Morphoea-like plaques revealing an eosinophilic (Shulman) fasciitisClinical and Experimental Dermatology, 2009
- Superficial thrombophlebitis of the venous dorsal arch of the foot and deep venous thrombosis after foam sclerotherapyInternational Journal of Dermatology, 2008
- Dapsone Treatment for Eosinophilic FasciitisArchives of Dermatology, 2008
- Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcomeClinical Rheumatology, 2007
- Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international studyRheumatology, 2005
- Eosinophilic fasciitis successfully treated with cyclosporineClinical Rheumatology, 2005
- Eosinophilic fasciitis: Clinical spectrum and therapeutic response in 52 casesSeminars in Arthritis and Rheumatism, 1988
- Diffuse (eosinophilic) fasciitis. A series of six casesClinical Rheumatology, 1984
- Eosinophilic Fasciitis:Review and Report of Six CasesScandinavian Journal of Rheumatology, 1979